Credit Suisse’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-48,981
| Closed | -$6K | – | 4228 |
|
|
2018
Q4 | $6K | Sell |
48,981
-156,024
| -76% | -$102K | ﹤0.01% | 3855 |
|
|
2018
Q3 | $348K | Sell |
205,005
-63,998
| -24% | -$115K | ﹤0.01% | 3461 |
|
|
2018
Q2 | $468K | Sell |
269,003
-27,441
| -9% | -$47.4K | ﹤0.01% | 3456 |
|
|
2018
Q1 | $543K | Buy |
296,444
+4,046
| +1% | +$8.55K | ﹤0.01% | 3323 |
|
|
2017
Q4 | $652K | Sell |
292,398
-53,880
| -16% | -$134K | ﹤0.01% | 3281 |
|
|
2017
Q3 | $1M | Sell |
346,278
-56,616
| -14% | -$193K | ﹤0.01% | 3096 |
|
|
2017
Q2 | $1.79M | Sell |
402,894
-325,458
| -45% | -$1.34M | ﹤0.01% | 2300 |
|
|
2017
Q1 | $3.4M | Buy |
728,352
+487,434
| +202% | +$2.83M | ﹤0.01% | 1933 |
|
|
2016
Q4 | $1.47M | Sell |
240,918
-7,109
| -3% | -$37.2K | ﹤0.01% | 2687 |
|
|
2016
Q3 | $1.37M | Buy |
248,027
+52,887
| +27% | +$248K | ﹤0.01% | 2688 |
|
|
2016
Q2 | $742K | Sell |
195,140
-87,125
| -31% | -$295K | ﹤0.01% | 3170 |
|
|
2016
Q1 | $780K | Buy |
282,265
+56,972
| +25% | +$206K | ﹤0.01% | 2914 |
|
|
2015
Q4 | $1.28M | Buy |
225,293
+39,038
| +21% | +$238K | ﹤0.01% | 2623 |
|
|
2015
Q3 | $988K | Sell |
186,255
-13,661
| -7% | -$106K | ﹤0.01% | 2834 |
|
|
2015
Q2 | $1.66M | Buy |
199,916
+107,541
| +116% | +$521K | ﹤0.01% | 2711 |
|
|
2015
Q1 | $427K | Sell |
92,375
-39,684
| -30% | -$129K | ﹤0.01% | 3651 |
|
|
2014
Q4 | $403K | Sell |
132,059
-1,847
| -1% | -$5.46K | ﹤0.01% | 3859 |
|
|
2014
Q3 | $373K | Sell |
133,906
-44,480
| -25% | -$161K | ﹤0.01% | 3818 |
|
|
2014
Q2 | $726K | Buy |
178,386
+48,193
| +37% | +$205K | ﹤0.01% | 3559 |
|
|
2014
Q1 | $691K | Buy |
130,193
+10,055
| +8% | +$56.4K | ﹤0.01% | 3460 |
|
|
2013
Q4 | $667K | Buy |
120,138
+28,308
| +31% | +$122K | ﹤0.01% | 3582 |
|
|
2013
Q3 | $414K | Sell |
91,830
-94,094
| -51% | -$422K | ﹤0.01% | 3604 |
|
|
2013
Q2 | $792K | Buy |
+185,924
| New | +$934K | ﹤0.01% | 2976 |
|
Other funds holding SGYP
Credit Suisse's SGYP Position: Q1 2019 in Review
Credit Suisse sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 48,981 shares — an estimated $6K sold.
Credit Suisse first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $3.4M in Q1 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Credit Suisse reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Credit Suisse sold 48,981 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $6K.
- Credit Suisse first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Credit Suisse's Synergy Pharmaceuticals, Inc Common Stock position peaked at $3.4M in Q1 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Credit Suisse's 13F filing for Q1 2019, filed 14 May 2019.